24/7 Market News Snapshot 08 August, 2025 – Capricor Therapeutics Inc (NASDAQ:CAPR)

August 8, 2025

DENVER, Colo., 08 August, 2025 (www.247marketnews.com) – (NASDAQ:CAPR) are discussed in this article.
Capricor Therapeutics Inc. has shown remarkable progress in recent trading, with shares opening at $7.91 and rising to $9.05, marking a gain of approximately 12.14% from the previous close of $8.07. The current trading volume, reaching 2.46 million shares, signifies increased investor interest, suggesting a bullish market sentiment. Analysts recommend monitoring critical support levels around $8.07 and a resistance mark near $9.50, as these will be vital for gauging future price movements and investment opportunities.

In conjunction with this market performance, Capricor has announced the scheduling of a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the regulatory pathway for its Biologics License Application (BLA) concerning Deramiocel. This innovative cell therapy candidate aims to treat cardiomyopathy linked to Duchenne muscular dystrophy (DMD). This strategic meeting signifies a key step in the company’s effort to bring Deramiocel to market, further enhancing its commitment to developing effective treatments for rare diseases.

As part of its strategic initiatives, Capricor has also postponed the release of its financial results for the second quarter ended June 30, 2025, now set for August 11, 2025, following market close. Management plans to conduct a conference call and webcast at 4:30 p.m. ET that same day, providing insights into their financial standing and updates on corporate progress.

Driven by a dedication to advancing therapeutics, Capricor is leveraging its innovative StealthX™ platform, which enables targeted therapeutic delivery and explores potential applications in so-called vaccinology. This underscores the company’s resolve to push the boundaries of medical advancement and deliver transformative therapies to enhance the quality of life for patients faced with rare diseases.

Related news for (CAPR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.